RISING BURDEN OF HEPATITIS C VIRUS (HCV) IN PAKISTAN: A CROSS SECTIONAL STUDY ON MULTITRANSFUSED BETA THALASSEMIA TYPE MAJOR PATIENTS
Keywords:
Abstract
Background: Hepatitis C virus (HCV) is a serious health issue which infected 3.3% of world’s population. The major transmission route of this virus is blood and blood products. Thalaseemic patients are dependent upon blood transfusions throughout their life and are at high risk of getting HCV infections.
Objectives: The aim of the study was to estimate the presence of hepatitis C virus in multitransfused thalaseemic population of capital twin cities of Pakistan.
Patients and Methods: The study was conducted from November 2021 to April 2022 and 262 multitransfused beta thalaseemic from the capital twin cities of Pakistan were enrolled for analysis. The presence of hepatitis C virus, alanine amino transferase (ALT) level, serum creatinine, hepatomegaly, splenomegaly and splenectomy were analyzed.
Results: The overall prevalence of Hepatitis C virus was 55.73% observed with 100% of patients greater than 20 years of age have HCV infection. The average ALT in HCV positive thalaseemic patients was observed 98U/L and average creatinine values were 0.39 mg/dl. 82.20% of HCV positive thalaseemic patients have hepatomegaly with average increase of 4.33 cm in liver size. Splenomegaly was observed in 67.12% of HCV positive thalaseemic patients with average increase of 4.46 cm in spleen size. Splenectomy was observed in 15.75% of cases.
Conclusion: The presence of HCV is very high in thalaseemic population of Pakistan. The chance of getting HCV infections also increases with the increase in age of thalaseemic patient. Raised ALT and hepatomegaly was observed in majority of HCV positive thalaseemic patients. There is a strong need to properly screen the blood before transfusions to decrease the future load of HCV from Pakistan.
Similar Articles
-
Formation Of Young People Of The Younger Generation In Uzbekistan As A Science-Driven Process
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Yu.M. Khalimbetov, Yuldashev S.J , Murodova U.R, -
National Processes In Uzbekistan And The Formation Of The Internationalist Maturity Of The Younger Generation
The American Journal of Medical Sciences and Pharmaceutical Research: No. 06 (2021) / Soatboy Yuldashev, Yusup Halimbetov, Marhabo Usmanova, Naimova Z.S, Khamraeva M, -
Indian Thermal Atmosphere And Surgery Result In Older Sufferer
The American Journal of Medical Sciences and Pharmaceutical Research: No. 07 (2020) / Abhishek Nigam , Anurag Panday, -
The Prevalence Of Metabolic Syndrome In Older People: “Attitude Towards Population Success”
The American Journal of Medical Sciences and Pharmaceutical Research: No. 01 (2021) / Mamasoliev N.S., Tursunov Kh.Kh., Rajabova G.Kh., -
PRINCIPLES OF MANAGEMENT OF PATIENTS WITH POST-STROKE SEIZURES
The American Journal of Medical Sciences and Pharmaceutical Research: No. 08 (2023) / Dilbar Tadzhievna Khodzhieva, -
MORPHOLOGICAL AND FUNCTIONAL FACTORS OF PARODONTAL AND HARD TISSUES DISEASES
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2022) / Nazarova Nodira Sharipovna, Ruzimurodova Zilola Shukhratovna, -
Features Of Verticalization In Early Rehabilitation Of Ischaemic Stroke And Diabetes Patients
The American Journal of Medical Sciences and Pharmaceutical Research: No. 09 (2021) / Pulatov Sadriddin Sayfullaevich, Ruziev Feruz Giyasovich, -
Emergency Preparedness and Innovative Response Plan for Smooth Congregations during COVID-19 pandemic: An Urgent Need for Comprehensive Approaches to Tactically Resolve Risk of SARS-CoV-2 or MERS-CoV Transmission
The American Journal of Medical Sciences and Pharmaceutical Research: No. 11 (2021) / Umar Saeed , Zahra Zahid Piracha , Sara Rizwan Uppal , Muhammad Saad Uppal , Aftab Ahmad Khan , Muhammad Erfan Khattak,
References
Feinstone, S, M., Kapikian, A, Z., Purcell, R, H., Alter, H, J., and Holland, P, V. (1975). Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med, 292: 767–770.
Alter, H,J., Holland, P,V., Morrow, A,G., Purcell, R, H., Feinstone, S, M., and Moritsugu, Y. (1975). Clinical and serological analysis of transfusion-associated hepatitus. Lancet, 2: 838–41.
Houghton, M. (2009). Discovery of the hepatitis C virus. Liver International, 29(s1): 82–88.
Wikipedia, Hepatitis C Virus. http://en.wikipedia.org/wiki/Hepatitis_C_virus.
World Health Organization. Hepatitis C. Available at: www.who.int/vaccine_research/viral_cancers. Retrieved on 16.4.2009.
World Health Organization, World Health Statistics Geneva. (2008). http://www.who.int/gho/ publications/world_health_statistics/EN_WHS08_Full.pdf
World Health Organization, Hepatitis C Fact sheet No.164. (2000). http://wwwwhoint/media centre/factsheets/fs164/en/
Denson Smith. Chronic Hepatitis C: Current disease management. (2005). http://digestive.niddh. govlddiseaseslpubslchYOnichepclindex htm.
Eduardo, Z,V. (2006). Transmission routes of hepatitis C virus infection. Annals of Hepatology, 5(1):S12-S14.
Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, etal. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect. 1997;119:349–56.
Jafri, S, M. (2003). Hepatitis C virus - the Pakistani perspective. J Coll Physicians Surg Pak, 13:431–2.
Aziz S, Muzaffar R, Hafiz S, Abbas Z, Zafar MN, Naqvi SA, et al. Helicobacter pylori, hepatitis viruses A, C, E, antibodies and HBsAg - prevalence and associated risk factors in pediatric communities of karachi. J Coll Physicians Surg Pak. 2007;17:195–8.
Jafri, W., and Subhan, A. (2008). Hepatitis C in Pakistan: Magnitude, Genotype, Disease Characteristics and Therapeutic Response. Tropical Gastroenterology, 29(4):194–201.
Aziz, S., Memon, A., Tily, H, I., Rasheed, K., Jehangir, K., and Quraishy, M, S. (2002). Prevalence of HIV, hepatitis B and C amongst health workers of Civil Hospital Karachi. J Pak Med Assoc, 52: 92-94.
Mujeeb, S,A., Khatri, Y., and Khanani, R. (1998). Frequency of parenteral exposure and seroprevalence of HBV, HCV, and HIV among operation room personnel. J Hosp Infect, 38:133–7.
World Health Organization (WHO) country office in Pakistan: Blood Safety. (2009). http://www.emro.who.int/pakistan/programmeareas_bloodsafety.htm.
World Health Organization. (2010). Global blood safety and availability, Key facts and figures. http://www.who.int/worldblooddonorday/media/Global_Blood_Safety_and_Availability_Key_facts_ figures_2010.pdf.
Pakistan Red Crescent Society. (2007). Types of Blood Donors. http://www.prcs.org.pk/ blood_types.asp.
Mujeeb, S, A. Who is replacement blood donor? A professional, family or voluntary donor., blood bank, JPMC, Karachi.
National AIDS Control Programme, National Blood Policy and Strategic Framework 2008-2012 for Blood Transfusion Services in Pakistan. (2012). http://www.nacp.gov.pk/introduction/ National_Blood_policy_&_strategic_framework-BT.pdf.
Ali N, Nadeem M, Qamar A, Qureshi AH, Ejaz A. Frequency of hepatitis C virus antibodies in blood donors in combined military hospital, Quetta. Pak J Med Sci. 2003;19(1):41-44.
Cheraghali AM. Blood safety concerns in the Eastern Mediterranean region. Hepat Mon. 2011;11(6):422-426.
Ahmed, S., Saleem, M., Modell, B., and Petrou, M. (2010). Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med, 347: 1162-68.
Afzal, M., Ali, S.M., Siyal, H.B. 1994. Consanguineous marriages in Pakistan. Pak. Dev. Rev. 33, 663-74.
Akhtar, S., and Moatter, T. (2004). Hepatitis C virus infection in polytransfused thalassemic children in Pakistan. Ind Pediatr, 41:1072– 3.
Abdul-Mujeeb, S., Shiekh, M, A., Khanani, R., and Jamal, Q. (1997). Prevalence of hepatitis C virus infection among beta-thalassaemia major patients. Trop Doct, 27:105.
Bhatti, F, A., Amin, M., and Saleem, M. (1995). Prevalence of antibody to hepatitis C virus in Pakistani thalassaemics by particle agglutination test utilizing C 200 and C 22-3 viral antigen coated particles. J Pak Med Assoc, 45:269–71.
Khokhar, N., Alam, A, Y., Naz, F., and Mahmud, S, N. (2005). Risk factors for hepatitis C virus infection in patients on long-term hemodialysis. J Coll Physicians Surg Pak, 15:326–8.
McCaughan, G, W. (2000). Asian perspectives on viral hepatitis: hepatitis C virus infection. J Gastroenterol Hepatol, 15:G90–3.
Afzaal Memorial Thalassemia Foundation. http://www.afzaalfoundation.org.
Daily Times, Monday October 03. (2011). http://dailytimes.com.pk/default.asp?page=2011%5 C10%5C03%5Cstory_3-10-2011_pg11_7.
Katsanos KH, Chaidos A, Christodoulou DK, Tzambouras N, Bourandas EZ, Tsianos EV. Epidemiological and clinical characteristics of HCV infection in transfusion-dependent thalassemia. Annals of Gastroenterology 2005 , 18(1) 56:64.
Mukherjee S, Dhawan VK. Hepatitis C. Available at: http://www.emedicine.com/med/topic993.htm.
WHO. Global surveillance and control of Hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999; 6:35-47.
Waheed Y, Shafi T, Safi SZ, Qadri I: Hepatitis C virus in Pakistan: A systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009 December 7; 15(45): 5647-5653.
Ahmad N, Asgher M, Shafique M, Qureshi JA. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan. Saudi Med J. 2007;28:390–5.
Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ. 2000;78:956–63.
Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassaemia and haemodialysis patients in North Iran-Rasht. J Virol Hepatol 2002; 9: 390-92.
Akhtar S, Moatter T, Azam SI, Rahbar MH, Adil S. Prevalence and risk factors for interfamilial transmission of hepatitis C virus in Karachi, Pakistan. Baillieres Clin Haematol 1998; 11: 147- 62.
Moatter T, Adil S, Haroon S, Azeemuddin S, Hassan F, Khurshid M. Prevalence of hepatitis G virus in Pakistani children with transfusion dependent beta- thalassemia major. Indian J Pathol Microbiol. 1999;42(4):475-82.
Muhammad J, Hussain M, Khan MA. Frequency of Hepatitis B and Hepatitis C infection in Thalassemic children. Pak Pediatr J 2003; 27: 161-164.
Younas M, Hassan K, Ikram N, Naseem L, Zaheer HA, Khan MF. Hepatitis C virus seropositivity in repeatedly transfused thalassemia major patients. Int J Pathol. 2004;2(1):20-3.
Burki MFK, Hassan M, Hussain H, Nisar YB, Krishan J. Prevalence of anti-hepatitis C antibodies in multiply transfused beta thalassemia major patients. Ann Pak Inst Med Sci. 2005;1(3):150–3.
Shah SMA, Khan MT, Zahour Ullah, Ashfaq NY. Prevalence of hepatitis B and hepatitis C virus infection in multitransfused thalassaemia major patients in North West Frontier Province. Pak J Med Sci 2005; 21: 281-284.
Hussain H, Iqbal R, Khan MH, Iftikhar B, Aziz S, Burki FK. Prevalence of hepatitis C in Beta thalassaemia major. Gomal J Med Sci 2008; 6: 87-90.
